Anthem Biosciences Limited has informed the Exchange about Copy of Newspaper Publication on Unaudited Standalone and Financial Results for the Quarter ended June 30, 2025
ANTHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Anthem Biosciences has informed BSE and NSE that it published its unaudited consolidated and standalone financial results for the quarter ended June 30, 2025 in two newspapers on August 14, 2025. The advertisements appeared in Financial Express (English edition) and Vishwavani (Kannada edition). This filing is a routine compliance submission under SEBI's Listing Regulations (Regulation 47), which requires listed companies to publish their quarterly financial results in newspapers. The company has also been formerly known as Anthem Biosciences Private Limited, indicating a recent conversion to a public company. The actual financial numbers are not disclosed in this filing — they would be in the detailed results submitted separately.
No direct impact on shareholders or stock price, as this is a procedural compliance filing. Investors should look for the separate detailed Q1 FY26 results filing to assess actual financial performance.